Janney Montgomery Scott Upgrades BioDelivery Sciences International (BDSI) to Buy
Get Alerts BDSI Hot Sheet
Rating Summary:
7 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 19
Join SI Premium – FREE
Janney Montgomery Scott upgraded BioDelivery Sciences International (NASDAQ: BDSI) from Neutral to Buy with a price target of $4.00 as Belbuca will be added as the preferred brand over Butrant on United Healthcare Formulary.
Analyst Ken Trbovich commented, "Endo International plc (NASDAQ: ENDP) has not yet announced, but clearly won preferred status for Belbuca relative to market leader Butrans on the Prescription Drug List at United Healthcare. ENDP's initial launch has been disappointing, but the United contract improves the outlook and is set to take effect on January 1, 2017. Additionally, BDSI has announced five contract wins for Bunavail since July. This places BDSI on a path to show meaningful growth for Bunavail growth in 2017. As a result, our preliminary 2017 BDSI revenue estimate of $25 mln shows significant improvement from our current 2016 estimate of $15 mln. Based on the improved outlook we are raising our rating to Buy and maintaining our $4 fair value estimate."
For an analyst ratings summary and ratings history on BioDelivery Sciences International click here. For more ratings news on BioDelivery Sciences International click here.
Shares of BioDelivery Sciences International closed at $2.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades Hancock Whitney (HWC) to Buy
- Morgan Stanley Upgrades Macquarie Group Ltd. (MQG:AU) (MQBKY) to Overweight
- Loop Capital Starts Samsara Inc (IOT) at Buy, 'Play on AI, ML, & IoT Tech Themes in Asset Intensive Industries'
Create E-mail Alert Related Categories
Analyst Comments, Hot Upgrades, UpgradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!